OR WAIT null SECS
Susan Haigney is lead editor of BioPharm International®.
March 02, 2023
The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines.
February 15, 2023
The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.
January 03, 2023
FDA sent a variety of warning letters to drug manufacturers at the end of 2022 highlighting myriad CGMP and quality control violations.
November 02, 2022
Industry experts discuss best practices for certificates of analysis.
September 02, 2022
It is important to understand regulatory requirements and study challenges to develop and validate the appropriate methods for a bioanalytical study program at the clinical stage.
August 31, 2022
Pharmaceutical Technology spoke with Andrew Anderson, Global Head Strategic Account Management and Mary Todas, Director Technical Development and Regulatory Affairs, both with Pfizer CentreOne, about best practices for API quality.